Funder: Alzheimer's Drug Discovery Foundation

Due Dates (Anticipated): September 2026 (Letter of Intent) | January 2027 (Invited full proposal)

Funding Amounts: Exploratory awards up to ~$250,000; proof-of-principle up to ~$500,000; larger amounts possible for validation; budgets based on stage and scope.

Summary: Supports development and validation of digital biomarkers for Alzheimer's disease and related dementias, from pilot studies to large-scale validation, with an emphasis on clinical and commercial translation.

Key Information: This is a forecasted opportunity; all dates are projected and subject to change.